Strides Pharma Science Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Pronomz Ventures LLP, was filed 24 Mar 2022.
Strides Pharma Science Limited: what insiders have been doing
Strides Pharma Science Limited, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEBI (PIT + SAST). No insider at Strides Pharma Science Limited has published a filing in the past twelve months. The most recent one dates from 24 March 2022.
Our records for Strides Pharma Science Limited go back to 2021, with 7 purchases and 14 sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Since the insiders bought
- -22.9%Entry ₹363.60 · Close at T+365 ₹280.50
- -17.0%Entry ₹333.35 · Close at T+365 ₹276.60
- -7.4%Entry ₹320.30 · Close at T+365 ₹296.55
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Strides Pharma Science Limited Strong Buy (bullish), based on 3 analysts. Average price target: ₹1,338.67.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 45,450 shares@ ₹350.684211.1% of flowEquity SharesSEBI:7b44e46e6ee249555dcb3809f062f27209ef52b0Canonical exit: 19 Jun 2022 (T+90)
- 53,200 shares@ ₹330.081812.3% of flowEquity SharesSEBI:6c93527891d2065eb9a74c359c908a92c9ff60faCanonical exit: 14 Jun 2022 (T+90)
- 300,000 shares@ ₹323.419100.0% of flowEquity SharesSEBI:69c86e43d509cb7ad07af91fa9ff3f831b7d1cc8Canonical exit: 12 Jun 2022 (T+90)
- 291,250 shares@ ₹320.789665.2% of flowEquity SharesSEBI:286771d5076760fe149bb2111c0338152f22f1ebCanonical exit: 2 Jun 2022 (T+90)
- 52,000 shares@ ₹318.020511.4% of flowEquity SharesSEBI:0af2be3627c09e7fa760032f7f9ebe920aca4bf3Canonical exit: 29 May 2022 (T+90)
- 1,550 shares@ ₹327.3065100.0% of flowEquity SharesSEBI:bc3c6e68d87cb728c3dc5735166c79e88641781dCanonical exit: 25 May 2022 (T+90)
- 155,200 shares@ ₹321.5921100.0% of flowEquity SharesSEBI:886558ffe2f68a95a80a67b294fae2d78d3a58adCanonical exit: 25 May 2022 (T+90)
- 2,600 shares@ ₹639.7592100.0% of flowEquity SharesSEBI:da4da765acbf12a1efc02a7bcbec8077fe37f9e2
- 4,000 shares@ ₹628.850367.7% of flowEquity SharesSEBI:bb89d6aeb99a1b397593d54f772b4b40a519282f
- 2,500 shares@ ₹602.30100.0% of flowEquity SharesSEBI:d336305a1693c2b445e9a62f1997ae6e7478c30e
- 4,000 shares@ ₹301.00100.0% of flowEquity SharesSEBI:41a366a4c8db04da99e25821bfdf6d7a7c2a2bea
- 3,750 shares@ ₹301.00100.0% of flowEquity SharesSEBI:e8d76ac4b9005e038030bd8ecc4c171196962632
- 3,750 shares@ ₹301.0028.8% of flowEquity SharesSEBI:43a75685095cb6fe8f5dc243b3c1243dacf97450
- 3,750 shares@ ₹301.00100.0% of flowEquity SharesSEBI:1478c8e242cf09836975e6560cf2d406f5026753
- 3,750 shares@ ₹301.0039.7% of flowEquity SharesSEBI:4f308a55bcecd1ca822cd6ad07991f38855c0941
- 4,000 shares@ ₹301.0032.3% of flowEquity SharesSEBI:05255a66d070fc71fce0544ea378e9c1ee91e8b4
- 20,000 shares@ ₹701.27120.018% mcap100.0% of flowEquity SharesSEBI:36d17328b8f0f6e50fe1f3a41bd8c1310388bb52
- 20,000 shares@ ₹269.7049.8% of flowEquity SharesSEBI:8a4f4b71affa6d0c9a21cfeb56e0d360739d7fa8
- 2,280 shares@ ₹766.39650.0022% mcap60.3% of flowEquity SharesSEBI:12bfeb5a913c22334278a88627fcd141a41ec583
- 2,500 shares@ ₹755.8960.0024% mcap100.0% of flowEquity SharesSEBI:449285e23e3f0b296482651a7b09c85585bbf6e7
- 3,750 shares@ ₹757.33090.0036% mcap71.2% of flowEquity SharesSEBI:c44a5a569cc57282acbe3344cbfadbeb8b3ef8ba
- 3,750 shares@ ₹378.40100.0% of flowEquity SharesSEBI:5332f868d4313d6d68d867427d27e7fbf28f4cc0
- 57,869 sharesEquity SharesSEBI:626d1ecea5c5e7ca5c5ec4be6c7b466347d0e70e
- 88,734 sharesEquity SharesSEBI:e2bf6e4ac4065df6c1c8fc0b1f112f91019d1ec6
- 61,122 sharesEquity SharesSEBI:888cd758f80a6a6a0c29777f4e18472d50e71df5
25 of 39 declarations
About Strides Pharma Science Limited
Strides Pharma Science Limited is an Indian pharmaceutical company focused on the manufacturing of generic drugs and healthcare products. It primarily operates on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
